You searched for "presentation"
#KnowYourDrops: breaking down barriers to poor compliance
Award-winning* #KnowYourDrops eye drop compliance campaign helps patients for World Glaucoma Week to achieve medicines optimisation in ophthalmology. The #KnowYourDrops campaign is fast becoming an internationally recognised model to help support healthcare professionals, with the provision of better tailored ophthalmic...The last three patients: dermatology (Patient Three)
For the third and final reflection in this series (see Part 1 and Part 2), Professor Jonathan Rees recounts his experience of a patient with cancer who was failed by the NHS, and how their inadequate treatment illuminates some issues...Bovine pericardium scleral patch graft associated scleritis: Ahmed valve implant for pupillary block glaucoma
Processed bovine pericardium is a lyophilised collagen sheet used as a surgical armamentarium. It renders the material antigenically inert with minimal inflammation [1]. Sclera patch pericardium graft (Tutopatch) is a collagenous membrane derived from solvent preserved, irradiated bovine pericardium [2]...Eye Surgeons of the Future
Who and where are the eye surgeons of the year 2040? Chien Wong reports from a London school's Careers Fair.Study calls for thorough investigation of patients with early signs of retinal vascular disease
Patients with the eye condition Paracentral Acute Middle Maculopathy (PAMM) would benefit from further investigation, as their risk of heart attacks and strokes may be greater than previously shown, suggests a new study led by researchers at Moorfields Eye Hospital NHS Foundation Trust.AOP Lifetime Achievement accolade for Professor David Whitaker
The prestigious award was presented to the optometrist and prominent researcher at a celebratory event on 25 February.WATCH EPISODE 12: Beyond 2020 with the Andean Medical Mission
Welcome to the 12th episode of Beyond 2020, the video series from Andean Medical Mission | Bolivian Medical Charity that looks at strategies to eliminate avoidable blindness in countries with developing eyecare services and shares ideas and solutions to common...
Intravitreal ranibizumab for the treatment of myopic CNV
The authors conducted a prospective study. Sixty-four patients (65 eyes) attended the 12-month follow-up examination. The mean patient age was 47.8 years. Fifty-five patients (86.0%) were females. All patients had pathologic myopia (a spherical equivalent of more than − 6.0...
